← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2008Last known activity
Jul 8, 2021
Acquired by Merck on Feb 21, 2019
Timeline
2000s
- Jul 1, 2008
Immune Design— Founded
2010s
- Feb 21, 2019
Merck— Acquired By
Drugs by trial phase (36 distinct, 32 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Communicable Diseases
- Coronaviridae Infections
- Coronavirus Infections
- Herpes Genitalis
- Herpes Zoster
- Immune System Diseases
- Infections
- Influenza, Human
- Influenza in Birds
- Leishmaniasis
- Leishmaniasis, Cutaneous
- Leishmaniasis, Mucocutaneous
- Leishmaniasis, Visceral
- Leprosy
- Liposarcoma
- Liposarcoma, Myxoid
- Lung Diseases
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Non-Hodgkin
- Malaria
- Malaria, Falciparum
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Nidovirales Infections
- Ovarian Neoplasms
- Pneumonia
- Pneumonia, Viral
- Respiratory Tract Diseases
- Respiratory Tract Infections
- RNA Virus Infections
- Sarcoma
- Sarcoma, Synovial
- Schistosomiasis
- Severe Acute Respiratory Syndrome
- Triple Negative Breast Neoplasms
- Tuberculosis
- Tuberculosis, Pulmonary
- Virus Diseases
Recent trials (38)
- NCT04927585CollaboratorPhase 1Jul 8, 2021
- NCT04365101Overall official - principal investigatorPhase 1/Phase 2May 13, 2020
- NCT04365101CollaboratorPhase 1/Phase 2May 13, 2020
- NCT04222985CollaboratorPhase 1/Phase 2Jan 30, 2020
- NCT03947437Study chairPhase 1/Phase 2Oct 31, 2019
- NCT03947437Lead sponsorPhase 1/Phase 2Oct 31, 2019
- NCT03915678CollaboratorPhase 2Jun 30, 2019
- NCT03820414Study directorPhase 1Jan 3, 2019
- NCT03820414CollaboratorPhase 1Jan 3, 2019
- NCT03799510CollaboratorPhase 2Dec 13, 2018
- NCT03722472Overall official - principal investigatorPhase 1Oct 2, 2018
- NCT03722472Lead sponsorPhase 1Oct 2, 2018
- NCT03520959Lead sponsorPhase 3Sep 30, 2018
- NCT03450122CollaboratorPhase 1Sep 13, 2018
- NCT03806686CollaboratorPhase 2May 31, 2018
Details
- Founded
- Seattle, WA, US Jul 1, 2008
- Last known activity
- Jul 8, 2021